Table 4. Repeat visits and antibiotic prescribing for upper respiratory tract infection (URTI) or sore throat within 1) 7 days, or; 2) 28 days of a prior presentation, overall and by visit number. Data are inclusive of all records in the five-year period from 2013 to 2017.
| Â | URTI N = 41,532 | Sore Throat N = 5,862 | ||
|---|---|---|---|---|
7-day, N (%) | 28-day, N (%) | 7-day, N (%) | 28-day, N (%) | |
Total episodes of repeat presentations | 2,533 | 4,449 | 283 | 440 |
Received ≥1 antibiotic prescription(s) | 1,516 (59.8%) | 2,743 (61.7%) | 245 (86.6%) | 385 (87.5%) |
 Any antibiotic prescribed at first visit | 839 (33.1%) | 1,629 (36.6%) | 196 (69.3%) | 319 (72.5%) |
 Any antibiotic prescribed at second visit | 903 (35.6%) | 1,631 (36.7%) | 106 (37.5%) | 193 (43.9%) |
 Any antibiotic prescribed at third and subsequent visit(s)a | 96/293 (32.8%) | 372/1,098 (33.9%) | 7/25 (28.0%) | 35/78 (44.9%) |
Received ≥1 Australian Therapeutic Guidelines recommended antibiotic(s) | 326 (12.9%) | 565 (12.7%) | 177 (62.5%) | 261 (59.3%) |
 Recommended antibiotic at first visit | 200 (7.9%) | 341 (7.7%) | 138 (48.8%) | 205 (46.6%) |
 Recommended antibiotic at second visit | 135 (5.3%) | 241 (5.4%) | 53 (18.7%) | 96 (21.8%) |
 Recommended antibiotic at third or subsequent visit(s)a | 14/293 (4.8%) | 53/1,098 (4.8%) | 3/25 (12.0%) | 15/78 (19.2%) |